Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Serum cholesterol and mTOR inhibitors: surrogate biomarker or epiphenomenon?
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Serum cholesterol and mTOR inhibitors: surrogate biomarker or epiphenomenon?
Serum cholesterol and mTOR inhibitors: surrogate biomarker or epiphenomenon? Clin Cancer Res. 2012 Jun 01; 18(11):2999-3001.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma, Renal Cell
Cholesterol
Female
Humans
Kidney Neoplasms
Male
Sirolimus